Aurobindo Pharma logo

Aurobindo Pharma shareholders and shareholding pattern

NSE: AUROPHARMABSE: 524804Pharmaceuticals & BiotechnologyMid Cap

Last close ₹1,571.70down ₹39.20 (2.43%)BSE ₹1,569.30

Share price at the NSE close on 23 Oct 2026. Previous close ₹1,610.90.

52-week range of traded prices to 23 Oct 2026
₹1,080.10Low, 24 Oct 2025₹1,740.00High, 24 Sep 2026
Market cap
₹90,432 Cr138th largest listed
P/E
24.4
P/B
2.4
Dividend yield
Nonein the last 12 months
ROE
10.5%
ROCE
11.5%
Debt to equity
0.20
Volume, NSE
6,50,60251.3% delivered

Who owns Aurobindo Pharma, filing by filing

Per cent of the company's shares. The last ten years of filings, from Dec 2016; the latest is the filing for Sep 2026.

Sep 2026 filing

  • Promoters51.88%
  • Foreign institutions17.41%
  • Indian institutions24.42%
  • GovernmentsNone
  • Individuals and others6.29%

Shareholding pattern, per cent, from Sep 2022

  • Promoters
  • Foreign institutions
  • Indian institutions
  • Governments
  • Individuals and others
Per centDec 2016Filed 9 JanMar 2017Filed 13 AprJun 2017Filed 13 JulSep 2017Filed 12 OctDec 2017Filed 10 JanMar 2018Filed 11 AprJun 2018Filed 11 JulSep 2018Filed 15 OctDec 2018Filed 24 JanMar 2019Filed 12 AprJun 2019Filed 19 JulSep 2019Filed 17 OctDec 2019Filed 10 JanMar 2020Filed 29 AprJun 2020Filed 17 JulSep 2020Filed 19 OctDec 2020Filed 19 JanMar 2021Filed 17 AprJun 2021Filed 16 JulSep 2021Filed 12 OctDec 2021Filed 17 JanMar 2022Filed 16 AprJun 2022Filed 18 JulSep 2022Filed 20 OctDec 2022Filed 17 JanMar 2023Filed 14 AprJun 2023Filed 19 JulSep 2023Filed 16 OctDec 2023Filed 8 JanMar 2024Filed 5 AprJun 2024Filed 9 JulSep 2024Filed 14 OctDec 2024Filed 13 JanMar 2025Filed 15 AprJun 2025Filed 15 JulSep 2025Filed 13 OctDec 2025Filed 13 JanMar 2026Filed 17 AprJun 2026Filed 15 JulSep 2026Filed 14 Oct
51.94%51.87%51.87%51.87%51.87%51.87%51.87%51.87%51.87%51.87%51.87%51.87%51.87%52.01%52.01%52.01%51.94%51.94%51.83%51.83%51.83%51.83%51.83%51.83%51.83%51.83%51.83%51.83%51.83%51.83%51.80%51.82%51.82%51.82%51.82%51.82%51.82%51.82%51.88%51.88%
Indian promoters48.86%48.80%48.80%48.80%48.80%48.80%48.80%48.80%48.80%48.80%48.80%48.80%48.80%48.94%48.94%48.94%48.86%48.86%48.76%48.76%48.76%48.76%48.76%48.76%48.76%48.76%48.76%48.76%48.76%48.76%48.73%48.75%48.75%48.75%48.75%48.75%48.75%48.75%48.81%48.80%
Foreign promoters3.08%3.07%3.07%3.07%3.07%3.07%3.07%3.07%3.07%3.07%3.07%3.07%3.07%3.07%3.07%3.07%3.07%3.07%3.07%3.07%3.07%3.07%3.07%3.07%3.07%3.07%3.07%3.07%3.07%3.07%3.07%3.07%3.07%3.07%3.07%3.07%3.07%3.07%3.07%3.07%
48.06%48.13%48.13%48.13%48.13%48.13%48.13%48.13%48.13%48.13%48.13%48.13%48.13%47.99%47.99%47.99%48.06%48.06%48.17%48.17%48.17%48.17%48.17%48.17%48.17%48.17%48.17%48.17%48.17%48.17%48.20%48.18%48.18%48.18%48.18%48.18%48.18%48.18%48.12%48.12%
Promoter shares pledgedShare of the promoters' own shares1.40%1.27%1.22%1.53%1.79%2.01%2.09%2.21%2.30%3.49%3.82%4.20%4.99%6.17%6.17%9.34%9.27%22.81%20.66%22.98%22.97%14.05%14.97%14.92%16.15%17.90%19.16%19.56%18.90%20.86%20.88%20.39%17.83%16.92%17.08%17.50%17.50%23.65%13.75%11.99%
Shares in issue58,51,69,58658,58,82,40958,58,82,40958,58,82,40958,58,82,40958,59,07,60958,59,07,60958,59,07,60958,59,07,60958,59,15,60958,59,15,60958,59,38,60958,59,38,60958,59,38,60958,59,38,60958,59,38,60958,59,38,60958,59,38,60958,59,38,60958,59,38,60958,59,38,60958,59,38,60958,59,38,60958,59,38,60958,59,38,60958,59,38,60958,59,38,60958,59,38,60958,59,38,60958,59,38,60958,59,38,60958,08,01,62358,08,01,62358,08,01,62358,08,01,62358,08,01,62358,08,01,62358,08,01,62357,53,77,89557,53,77,895
Filings before Sep 2022 are on an older form, which did not split institutions into foreign and Indian and grouped some holders differently, so those columns show only the lines both forms state alike. Pledged is the share of the promoters' own shares given to lenders as security. A dash is a line the filing did not state. “Under 0.01%” is a holding of shares too small to show at two decimals.

Number of Aurobindo Pharma shareholders

Shareholders on the company's register in each filing.

Shareholders, filing by filing

ShareholdersDec 2016Filed 9 JanMar 2017Filed 13 AprJun 2017Filed 13 JulSep 2017Filed 12 OctDec 2017Filed 10 JanMar 2018Filed 11 AprJun 2018Filed 11 JulSep 2018Filed 15 OctDec 2018Filed 24 JanMar 2019Filed 12 AprJun 2019Filed 19 JulSep 2019Filed 17 OctDec 2019Filed 10 JanMar 2020Filed 29 AprJun 2020Filed 17 JulSep 2020Filed 19 OctDec 2020Filed 19 JanMar 2021Filed 17 AprJun 2021Filed 16 JulSep 2021Filed 12 OctDec 2021Filed 17 JanMar 2022Filed 16 AprJun 2022Filed 18 JulSep 2022Filed 20 OctDec 2022Filed 17 JanMar 2023Filed 14 AprJun 2023Filed 19 JulSep 2023Filed 16 OctDec 2023Filed 8 JanMar 2024Filed 5 AprJun 2024Filed 9 JulSep 2024Filed 14 OctDec 2024Filed 13 JanMar 2025Filed 15 AprJun 2025Filed 15 JulSep 2025Filed 13 OctDec 2025Filed 13 JanMar 2026Filed 17 AprJun 2026Filed 15 JulSep 2026Filed 14 Oct
All shareholders1,67,6291,91,3172,08,1391,89,8522,02,2572,18,0292,15,0501,89,5701,88,0721,76,4061,79,9051,81,4322,00,3682,06,8241,93,0032,53,0512,19,3772,32,6342,43,3153,29,9403,41,5683,38,6393,59,6843,58,4593,69,8283,43,6172,93,2142,59,6382,41,9442,44,5752,38,6222,48,4882,57,9622,69,3232,72,2082,47,6622,36,8592,41,2982,39,0732,33,737
13131313141413131313131313141414141414141414141414141414141414141414141414141414
Indian promoters12121212131312121212121212131313131313131313131313131313131313131313131313131313
Foreign promoters1111111111111111111111111111111111111111
1,67,6161,91,3042,08,1261,89,8392,02,2432,18,0152,15,0371,89,5571,88,0591,76,3931,79,8921,81,4192,00,3552,06,8101,92,9892,53,0372,19,3632,32,6202,43,3013,29,9263,41,5543,38,6253,59,6703,58,4453,69,8143,43,6032,93,2002,59,6242,41,9302,44,5612,38,6082,48,4742,57,9482,69,3092,72,1942,47,6482,36,8452,41,2842,39,0592,33,723
Filings before Sep 2022 are on an older form, which did not split institutions into foreign and Indian and grouped some holders differently, so those columns show only the lines both forms state alike. A dash is a line the filing did not state.

Aurobindo Pharma promoters

Promoters are the founders, families and companies that control the company, as its filings name them. Every member of the promoter group holding shares in the filing for Sep 2026; the largest is RPR SONS ADVISORS PRIVATE LIMITED, MRS.P.SUNEELA RANI (JOINTLY HOLDING), 33.54%. The filing names 1 more member with no shares.Promoter buying and selling

Holder
RPR SONS ADVISORS PRIVATE LIMITED, MRS.P.SUNEELA RANI (JOINTLY HOLDING)Indian companies, trusts and others33.54%19,29,97,92310.95%
KAMBAM NITHYANANDA REDDYIndividuals and Hindu undivided families4.37%2,51,48,05241.55%
KIRTHI REDDY KAMBAMIndividuals and Hindu undivided families3.46%1,99,01,63513.57%
VENKATA RAMPRASAD REDDY PENAKANon-resident and foreign individuals3.07%1,76,90,3410.00%
AXIS CLINICALS LIMITED, TRIDENT CHEMPHAR LIMITED, RPR SONS ADVISORS PVT.LTD. (JOINTLY HOLDING)Indian companies, trusts and others2.86%1,64,38,9630.00%
MEENAKSHISUNDERAM SIVAKUMARANIndividuals and Hindu undivided families2.48%1,42,42,0610.00%
KAMBAM SPOORTHIIndividuals and Hindu undivided families1.20%68,83,4145.81%
KOTTAMANCHI RAJESWARIIndividuals and Hindu undivided families0.31%17,94,10011.15%
M SUMANTH KUMAR REDDYIndividuals and Hindu undivided families0.27%15,72,47750.88%
TRIDENT CHEMPHAR LIMITEDIndian companies, trusts and others0.13%7,75,9570.00%
AXIS CLINICALS LIMITEDIndian companies, trusts and others0.11%6,46,6820.00%
PRASADA REDDY KAMBHAMIndividuals and Hindu undivided families0.05%2,70,97636.90%
Pledged is the share of the holder's own shares pledged to a lender.

Largest public holders of Aurobindo Pharma, filing by filing

Per cent, on the same shares as the split above.Mutual funds holding Aurobindo Pharma

HolderDec 2016Filed 9 JanMar 2017Filed 13 AprJun 2017Filed 13 JulSep 2017Filed 12 OctDec 2017Filed 10 JanMar 2018Filed 11 AprJun 2018Filed 11 JulSep 2018Filed 15 OctDec 2018Filed 24 JanMar 2019Filed 12 AprJun 2019Filed 19 JulSep 2019Filed 17 OctDec 2019Filed 10 JanMar 2020Filed 29 AprJun 2020Filed 17 JulSep 2020Filed 19 OctDec 2020Filed 19 JanMar 2021Filed 17 AprJun 2021Filed 16 JulSep 2021Filed 12 OctDec 2021Filed 17 JanMar 2022Filed 16 AprJun 2022Filed 18 JulSep 2022Filed 20 OctDec 2022Filed 17 JanMar 2023Filed 14 AprJun 2023Filed 19 JulSep 2023Filed 16 OctDec 2023Filed 8 JanMar 2024Filed 5 AprJun 2024Filed 9 JulSep 2024Filed 14 OctDec 2024Filed 13 JanMar 2025Filed 15 AprJun 2025Filed 15 JulSep 2025Filed 13 OctDec 2025Filed 13 JanMar 2026Filed 17 AprJun 2026Filed 15 JulSep 2026Filed 14 Oct
LIFE INSURANCE CORPORATION OF INDIAInsurance companies–––––––––––––––––1.91%3.46%4.34%5.33%5.48%5.48%5.48%5.57%5.57%5.55%5.43%3.81%3.38%2.78%2.08%2.08%2.45%2.49%2.91%2.91%2.93%2.94%2.85%
NPS TRUST A/C - SBI PENSION FUND - UPS - CG SCHEMProvident and pension funds––––––––––––––––––––––––––––––––––––2.23%––2.80%
NPS TRUST - A/C SBI PENSION FUND SCHEME - NPS TIERProvident and pension funds––––––––––––––––––––––––––––––––––––––2.74%–
NPS TRUST- A/C ICICI PRUDENTIAL PENSION FUND SCHEMProvident and pension funds–––––––––––––––––––––––––––––––1.57%1.92%2.20%2.10%2.11%–2.34%In concert–
BNP PARIBAS FINANCIAL MARKETSForeign portfolio investors, category I––––––––––––––––––––––––––––1.62%–––––––––––
BNP PARIBAS ARBITRAGEForeign portfolio investors, category I–––––––––––––1.07%1.04%1.08%1.21%In concert1.22%1.22%1.15%1.19%1.12%1.19%1.22%In concert1.24%1.41%––––––––––––
INVESCO ASIAN EQUITY INCOME FUND (UK)Foreign portfolio investors, category I––––––––––––––––––––––––In concertIn concert1.12%–––––––––––––
BNP PARIBAS ARBITRAGE - ODIForeign portfolio investors, category I–––––––––––––In concertIn concertIn concertIn concert1.26%In concertIn concertIn concertIn concertIn concertIn concertIn concert1.37%In concertIn concert––––––––––––
INVESCO PACIFIC FUND (UK)Foreign portfolio investors, category I––––––––––––––––––––––––1.05%1.17%In concert–––––––––––––
SAUDI ARABIAN MONETARY AUTHORITY - EMERGING MARKETInstitutions Foreign Portfolio Investor––––––––––––––––––1.03%–––––––––––––––––––––
ICICI PRUDENTIAL LIFE INSURANCE COMPANY LIMITEDOther Institutions–––––––––––––––––1.01%––––––––––––––––––––––
ABU DHABI INVESTMENT AUTHORITY - BEACONInstitutions Foreign Portfolio Investor–––––––––––1.11%1.05%1.04%––––––––––––––––––––––––––
AMANSA HOLDINGS PRIVATE LIMITEDInstitutions Foreign Portfolio Investor–––––1.18%1.20%1.20%1.08%1.08%1.14%1.26%1.17%–––––––––––––––––––––––––––
STICHTING DEPOSITARY APG EMERGING MARKETS EQUITY POOLInstitutions Foreign Portfolio Investor1.09%1.10%–1.07%1.04%–––––––––––––––––––––––––––––––––––
JHUNJHUNWALA RAKESH RADHESHYAMResident individuals, over ₹2 lakh at face value–1.08%1.12%–––––––––––––––––––––––––––––––––––––
ABU DHABI INVESTMENT AUTHORITY - BEHAVEInstitutions Foreign Portfolio Investor1.31%1.02%–––––––––In concert–In concert––––––––––––––––––––––––––
RAKESH JHUNJHUNWALAResident individuals, over ₹2 lakh at face value1.09%–––––––––––––––––––––––––––––––––––––––
A filing names every holder above one per cent, in the company's own words: an insurer's holding can carry one of its funds' names. Mutual funds are left out here: each fund's holding is on the Mutual funds tab, from its own portfolio. A dash is a filing that did not name the holder, which includes holding under one per cent. “In concert” is a filing that named the holder only among the persons acting in concert; the latest filing's list is below.

Persons acting in concert

From the filing for Sep 2026.

NameHoldingShares
QUANT MUTUAL FUND - QUANT ARBITRAGE FUND0.01%49,500
QUANT MUTUAL FUND - QSIF SECTOR ROTATION LONG - SHORT FUND0.00%10,948
QUANT MUTUAL FUND - QUANT DYNAMIC ASSET ALLOCATION FUND0.09%4,96,695
QUANT MUTUAL FUND - QUANT BUSINESS CYCLE FUND0.10%5,77,381
QUANT MUTUAL FUND - QUANT MANUFACTURING FUND0.07%4,23,544
QUANT MUTUAL FUND - QUANT HEALTHCARE FUND0.02%1,29,172
QUANT MUTUAL FUND - QUANT MOMENTUM FUND0.12%7,08,612
QUANT MUTUAL FUND - QUANT CONSUMPTION FUND0.02%96,058
QUANT MUTUAL FUND-QUANT ELSS TAX SAVER FUND1.16%66,52,259
QUANT MUTUAL FUND - QUANT MID CAP FUND0.85%49,02,846
QUANT MUTUAL FUND - QUANT AGGRESSIVE HYBRID FUND0.18%10,12,165
QUANT MUTUAL FUND - QUANT MULTI CAP FUND0.74%42,57,303
Shareholders who act together in the company, with what each holds. The list can repeat holders shown above, under another name or as one of a fund house's schemes.